16:14 EDT PTC Therapeutics sees 2024 revenue $700M-$750M, consensus $749.22M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- Is PTCT a Buy, Before Earnings?
- PTC Therapeutics submits sepiapterin NDA to U.S. FDA
- Truist healthcare analyst holds an analyst/industry conference call
- PTC Therapeutics price target raised to $32 from $30 at Morgan Stanley